INMAS develops India's first indigenous anti-nuclear medical kit

Image
Press Trust of India New Delhi
Last Updated : Sep 13 2018 | 4:00 PM IST

In a major shot in the arm for paramilitary and police forces, scientists at a central research institute claim to have developed India's first indigenous medical kit that may ensure protection from serious injuries and faster healing of wounds resulting from nuclear warfare or radioactive leakage.

The kit, developed after two decades of work by the Institute of Nuclear Medicine and Allied Sciences (INMAS) here, has over 25 items, including radio-protectors that provide 80-90 per cent protection against radiation and nerve gas agents, bandages that absorb radiation as well as tablets and ointments.

Developed in India for the first time, it's a potent alternative to similar kits that were till now being procured from strategically advanced nations such as the US and Russia at much higher prices, INMAS Director A K Singh told PTI.

The contents include an advanced form of Prussian blue tablets, highly effective in incorporating Radio Cesium (Cs-137) and Radio Thallium, among the most feared radioisotopes in nuclear bombs that destroy human body cells.

The tablet provides 100 per cent absorption from the gut and other portals of entry to the human body, according to documents inside the medical kit accessed by PTI.

According to INMAS, the kit has been developed for the armed, paramilitary and police forces only as they are the first ones likely to get exposed to radiation -- be it during nuclear, chemical and biomedical (NCB) warfare or a rescue operation after a nuclear accident.

The kit also has an Ethylenediaminetetraacetic acid (EDTA) injection that traps uranium in the guts and blood of victims during a nuclear accident or warfare.

The kit also has Ca-EDTA Respiratory Fluid, which is the inhalation formula for chelation, or grabbing, of heavy metals and radioactive elements deposited in lungs through inhalation at nuclear accident sites.

When EDTA is injected into the veins, it "grabs" heavy metals and minerals and removes them from the body.

The medicine reduces the body burden of radioactivity by 30-40 per cent in controlled conditions and is highly useful for the rescue teams and victims after a nuclear accident.

According to INMAS, different paramilitary forces are processing Memorandums of Understanding (MoUs) with the Institute for seamless procurement of the product.

In some ways, medical and health issues faced by the military and the paramilitary are quite different to that of the general public. The three areas of particular concern to the defence sector are high altitudes, war injuries and NBC warfare," Singh told PTI.

Stating that the pharmaceutical industry is a mere spectator due to the limited commercial scope in such products, Singh said, Government sponsored research is the only way forward in this area with practically no import potential."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 13 2018 | 4:00 PM IST

Next Story